In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Parker has been overseeing pretrial hearings for Mangione, who is accused of fatally shooting UnitedHealthcare CEO Brian ...

Luigi Mangione’s pre-trial judge is married to a former executive at Pfizer, according to a shocking report. Magistrate Judge ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

High-yield dividend stocks often catch investors' attention -- and for good reason. When established companies maintain ...

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...

Plenty of high-performing growth stocks pay dividends -- such as Apple and Nvidia -- and though their dividend yields can be ...

The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.

Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

Shares of Pfizer Inc. PFE inched 0.11% higher to $26.74 Tuesday, on what proved to be an all-around great trading session for ...